SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) |
2 Months Ended | 3 Months Ended | 6 Months Ended | 8 Months Ended | 9 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2021 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Sep. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Allocation of Net loss | $ (17,808,000) | $ (17,808,000) | |||||||||
Net (loss)/income | $ (176,384,000) | $ (18,128,000) | $ (52,613,000) | $ (24,703,000) | $ (73,151,000) | $ (58,583,000) | |||||
Founder Spac [Member] | |||||||||||
Net (loss)/income | $ (915,705) | ||||||||||
Class A accretion to redemption amount | (4,743,750) | ||||||||||
Allocation of Net loss | $ 8,529 | $ 240,071 | 810,422 | (5,659,455) | |||||||
Net (loss)/income | $ 915,705 | ||||||||||
Common Class B [Member] | Founder Spac [Member] | |||||||||||
Share outstanding | 7,906,250 | 7,906,250 | |||||||||
Allocation of Net loss | $ 8,529 | $ 48,014 | $ 162,084 | $ (1,131,891) | |||||||
Net (loss)/income | $ (1,131,891) | ||||||||||
Weighted Average Shares outstanding | 7,906,250 | 7,906,250 | 7,906,250 | 7,906,250 | |||||||
Basic and diluted net loss per common stock | $ (0.00) | $ (0.01) | $ (0.02) | $ (0.14) | |||||||
Share Outstanding | 7,906,250 | 7,906,250 | 7,906,250 | ||||||||
Common Class A [Member] | Founder Spac [Member] | |||||||||||
Proceeds allocated to Class A | $ 316,250,000 | ||||||||||
Class A redemption amount | 320,993,750 | ||||||||||
Allocation of Net loss | $ 192,057 | $ 648,338 | (4,527,564) | ||||||||
Accretion of Class A to redemption value | 4,743,750 | ||||||||||
Net (loss)/income | $ 216,186 | ||||||||||
Weighted Average Shares outstanding | 31,625,000 | 31,625,000 | 9,271,586 | ||||||||
Basic and diluted net loss per common stock | $ (0.01) | $ (0.02) | $ 0.02 | ||||||||
Common Class A [Member] | Founder Spac [Member] | IPO [Member] | |||||||||||
Share outstanding | 31,625,000 | 31,625,000 | |||||||||
Shares Issued upon IPO | 31,625,000 | 31,625,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cash inflow from the issuance of equity classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share. No definition available.
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|